Vitamin D Council needs your help...

Tax-deductible!

Together we can end the illness and disease caused by the worldwide epidemic of vitamin D deficiency.

About Vitamin D Council

Contact Vitamin D Council

Sponsor Vitamin D Council

Follow us on:

Vitamin D Products

(off-site)

These companies donate to the Vitamin D Council.

D-Lite, Renew, & SunSplash UV/Tanning Systems
In-Home ZRT Vitamin D Blood Test Kit
Get Premium Quality Vitamin D Supplements at Great Prices
Vitamin D3 Plus™ from Bio-Tech — contains the cofactors Vitamin D needs to work properly.

Vitamin D Research

back to research menu

Tuberculosis

Effect of vitamin D on tuberculosis and HIV replication depends on conversion to calcitriol and concentration. Am J Respir Crit Care Med. 2009 Oct 15;180(8):795; author reply 795–6.
Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis. Clin Immunol. 2009 Oct;133(1):126–31.
Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J. 2009 Sep 24.
Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe. 2009 Sep 17;6(3):231–43.
A vitamin for autophagy. Cell Host Microbe. 2009 Sep 17;6(3):201–3.
1alpha,25-dihydroxyvitamin D inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology. 2009 Aug;127(4):539–48.
Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract. 2009 Jul–Aug;15(5):438–49.
Improved vitamin D status despite allocation to placebo in a tuberculosis treatment trial: contamination bias? Am J Respir Crit Care Med. 2009 Jul 15;180(2):189; author reply 189–90.
Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol. 2009 Jul;29(4):470–8.
Mycobacterium Tuberculosis, Autoimmunity, and Vitamin D. Clin Rev Allergy Immunol. 2009 Jun 20.
Vitamin D for Treatment and Prevention of Infectious Diseases: A Systematic Review of Randomized Controlled Trials. Endocr Pract. 2009 Jun 2:1–29.
Vitamin D receptor homozygote mutant tt and bb are associated with susceptibility to pulmonary tuberculosis in the Iranian population. Int J Infect Dis. 2009 May 29.
Vitamin D as Adjunctive Therapy in Refractory Pulmonary Tuberculosis: A Case Report. South Med J. 2009 May 7.
Vitamin d and tuberculosis: new light on a potent biologic therapy? Am J Respir Crit Care Med. 2009 May 1;179(9):740–2.
Vitamin D as Supplementary Treatment for Tuberculosis — A Double-blind Randomized Placebo-controlled Trial. Am J Respir Crit Care Med. 2009 May 1;179(9):843–50.
Vitamin D and tuberculosis. Nutr Rev. 2009 May;67(5):289–93.
Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Braz J Med Biol Res. 2009 Apr;42(4):312–22.
5' regulatory and 3' untranslated region polymorphisms of vitamin D receptor gene in south Indian HIV and HIV-TB patients. J Clin Immunol. 2009 Mar;29(2):196–204.
Regulatory role of 1, 25-dihydroxyvitamin D3 and vitamin D receptor gene variants on intracellular granzyme A expression in pulmonary tuberculosis. Exp Mol Pathol. 2009 Feb;86(1):69–73.
The Vitamin D Connection to Pediatric Infections and Immune Function. Pediatr Res. 2009 Jan 28.
Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients. Int J Tuberc Lung Dis. 2009 Jan;13(1):119–25.
Does vitamin D make the world go 'round'? Mol Aspects Med. 2008 Dec;29(6):369–75. Review.
Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr. 2008 Dec;138(12):2474–80.
The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008 Dec;29(6):369–75. Review.
IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol. 2008 Nov 15;181(10):7115–20.
Functional gene polymorphisms in canadian aboriginal populations with high rates of tuberculosis. J Infect Dis. 2008 Oct 15;198(8):1175–9.
Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006086. Review.
Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J. 2008 Oct;27(10):941–2.
Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol. 2008 Aug;20(4):371–6. Review.
The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):408–15. Review.
Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):348–52. Review.
Regulatory role of promoter and 3' UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis. J Clin Immunol. 2008 Jul;28(4):306–13.
L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol. 2008 Jul;16(7):336–44. Review.
Regulatory region polymorphisms of vitamin D receptor gene in pulmonary tuberculosis patients and normal healthy subjects of south India. Int J Immunogenet. 2008 Jun;35(3):251–4.
The effect of ultraviolet B-induced vitamin D levels on host resistance to Mycobacterium tuberculosis: a pilot study in immigrant Asian adults living in the United Kingdom. Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):97–8.
Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008 Mar;127(3):229–38. Review.
Human genes in TB infection: their role in immune response. Monaldi Arch Chest Dis. 2008 Mar;69(1):24–31. Review.
Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis. 2008 Feb 1;46(3):443–6.
Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008 Feb;37(1):113–9. Review.
Synergistic action of vitamin D and retinoic acid restricts invasion of macrophages by pathogenic mycobacteria. J Microbiol Immunol Infect. 2008 Feb;41(1):17–25.
First Homo erectus from Turkey and implications for migrations into temperate Eurasia. Am J Phys Anthropol. 2008 Jan;135(1):110–6.
Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. J Bone Miner Res. 2007 Dec;22 Suppl 2:V20–4. Review.
Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr. 2007 Nov;86(5):1376–83.
Vitamin D in defense of the human immune response. Ann N Y Acad Sci. 2007 Nov;1117:94–105. Review.
1, 25 Dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis. Cytokine. 2007 Nov;40(2):128–34.
Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax. 2007 Nov;62(11):1003–7.
DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun. 2007 Sep;8(6):456–67.
Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007 Aug 15;179(4):2060–3.
A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007 Jul 15;176(2):208–13.
What is new in vitamin D: 2006–2007. Curr Opin Rheumatol. 2007 Jul;19(4):383–8.
Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb). 2007 Jul;87(4):295–302.
Vitamin D receptor gene polymorphisms and susceptibility M. tuberculosis in native Paraguayans. Tuberculosis (Edinb). 2007 Jul;87(4):329–37.
IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol. 2007 Jun 1;178(11):7190–8.
Vitamin D3 and the immune system: maintaining the balance in health and disease. Nutr Res Rev. 2007 Jun;20(1):106–18.
The sunshine cure. Nat Med. 2007 Apr;13(4):396–7.
Key issues in the diagnosis and management of tuberculosis. J R Soc Med. 2007 Mar;100(3):134–41. Review.
Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):793–8. Review.
Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol Immunol. 2007 Mar;44(9):2213–20.
Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007 Jan;62(1):23–8.
Health issues in newly arrived African refugees attending general practice clinics in Melbourne. Med J Aust. 2006 Dec 4–18;185(11–12):602–6.
Study on the association of two polymorphisms of the vitamin D receptor (VDR) gene with the susceptibility to pulmonary tuberculosis (PTB) in Chinese Tibetans. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Nov;37(6):847–51.
Vitamin D as a defensin. J Musculoskelet Neuronal Interact. 2006 Oct–Dec;6(4):344–6.
Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum Immunol. 2006 Aug;67(8):643–54.
Fighting infections with vitamin D. Nat Med. 2006 Apr;12(4):388–90.
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006 Mar 24;311(5768):1770–3.
The effect of vitamin D as adjuvant therapy in pulmonary tuberculosis with moderate-advance lesion. Acta Med Indones. 2006 Jan–Mar;38(1):1–2.
The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006 Jan–Mar;38(1):3–5.
Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis. 2005 Oct;9(10):1174–7.
Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect. 2005 Jun;50(5):432–7.
Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. Asian Pac J Cancer Prev. 2005 Apr–Jun;6(2):147–52.
Hypercalcemia in hepatic tuberculosis: a case report in Korea. Am J Trop Med Hyg. 2005 Apr;72(4):368–9.
Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Twin Res. 2004 Dec;7(6):578–88.
Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Twin Res. 2004 Dec;7(6):578–88.
Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med. 2004 Nov 1;170(9):967–73.
Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis. 2004 Nov 1;190(9):1631–41.
Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 Sep 1;338(2):143–56. Review.
Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg. 2004 Sep;71(3):341–9.
High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal disease. Clin Nephrol. 2004 Sep;62(3):202–7.
Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol. 2004 Sep;24(5):523–32.
Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis. 2004 Sep 1;190(5):920–7.
Chalk and cheese: symptomatic hypocalcaemia during paediatric anti-tuberculous therapy. J Infect. 2004 Aug;49(2):169–71.
Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis. J Clin Immunol. 2004 May;24(3):249–57.
Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):187–93.
VDR and NRAMP1 gene polymorphisms in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control study. Int J Tuberc Lung Dis. 2004 Apr;8(4):428–34.
Differential expression of apoptosis-related gene induced by clinical and laboratory Mycobacterium tuberculosis strain in macrophages U937 revealed by oligonucleotide microarray. Yi Chuan Xue Bao. 2004 Mar;31(3):231–5.
The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant. 2004 Feb;19(2):433–8.
Vitamin D receptor gene variants of BsmI, ApaI, TaqI, and FokI polymorphisms in spinal tuberculosis. Clin Genet. 2004 Jan;65(1):73–6.
Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. Microb Pathog. 2004 Jan;36(1):11–7.
Vitamin D receptor gene polymorphism is associated with chronic periodontitis. Life Sci. 2003 Nov 14;73(26):3313–21.
1,25-dihydroxyvitamin D3 and development of tuberculosis in cattle. Clin Diagn Lab Immunol. 2003 Nov;10(6):1129–35.
Genetics of susceptibility and resistance to tuberculosis. Internist (Berl). 2003 Nov;44(11):1385–93. Review.
Tuberculosis in compromised hosts. Kekkaku. 2003 Nov;78(11):717–22.
Vitamin D3-dependent pathway regulates TACO gene transcription. Biochem Biophys Res Commun. 2003 Oct 24;310(3):876–7.
Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003 May;89(5):552–72. Review.
A case-control study on the vitamin D receptor gene polymorphisms and susceptibility to pulmonary tuberculosis. Zhonghua Liu Xing Bing Xue Za Zhi. 2003 May;24(5):389–92.
Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production. J Cosmet Dermatol. 2003 Apr;2(2):86–98.
Vitamin D deficiency and tuberculosis: need for vitamin D food fortification. J Assoc Physicians India. 2003 Mar;51:326.
Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun. 2003 Jan;4(1):4–11. Review.
Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis. 2002 Nov 15;186(10):1463–8.
Tuberculosis and vitamin D deficiency. J Assoc Physicians India. 2002 Apr;50:554–8.
Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription. Mol Cell Biol. 2002 Apr;22(8):2777–87.
Vitamin D deficiency in UK Asian families: activating a new concern. Arch Dis Child. 2002 Mar;86(3):147–9. Review.
Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif. 2002;20(5):477–80. Review.
The genetics of host resistance and susceptibility to tuberculosis. Ann N Y Acad Sci. 2001 Dec;953:151–6. Review.
Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D(3). Clin Diagn Lab Immunol. 2001 Nov;8(6):1204–12.
Sarcoidosis within a pituitary adenoma. Pituitary. 2001 Aug;4(3):195–202.
Health problems among immigrant children in Norway. Tidsskr Nor Laegeforen. 2001 Feb 28;121(6):715–8.
Hypercalcaemia and elevated 1,25(OH)(2)D(3) levels associated with disseminated Mycobacterium avium infection in AIDS. J Infect. 2001 Feb;42(2):157–8.
The role of human genetic factors in susceptibility to tuberculosis. Acta Cient Venez. 2001;52 Suppl 1:16–8.
Influence of non-MHC genes on lymphocyte response to Mycobacterium tuberculosis antigens & tuberculin reactive status in pulmonary tuberculosis. Indian J Med Res. 2000 Sep;112:86–92.
Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int. 2000 Jun;66(6):476–8.
Applying experiences from trials of bacille Calmette-Guérin vaccine. Clin Infect Dis. 2000 Jun;30 Suppl 3:S262–5. Review.
Human genetic susceptibility to tuberculosis. Ann Acad Med Singapore. 2000 May;29(3):298–304. Review.
Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts. Indian J Med Res. 2000 May;111:172–9.
Identifying genetic susceptibility factors for tuberculosis in Africans: a combined approach using a candidate gene study and a genome-wide screen. Clin Sci (Lond). 2000 Mar;98(3):245–50.
Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000 Feb 19;355(9204):618–21.
Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant. 2000;15 Suppl 5:18–24. Review.
Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients. J Nephrol. 1999 Nov–Dec;12(6):398–403.
Tuberculosis treatment for the beginning of the next century. Int J Tuberc Lung Dis. 1999 Aug;3(8):651–62. Review.
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis. 1999 Mar;179(3):721–4.
Association of vitamin D receptor genotype with leprosy type. J Infect Dis. 1999 Jan;179(1):187–91.
Unaccountable severe hypercalcemia in a patient treated for hypoparathyroidism with dihydrotachysterol. Neth J Med. 1999 Jan;54(1):16–20.
Seasonal variations in vitamin-D status and the incidence of tuberculosis in different countries. Respiration. 1999;66(2):196. Review.
Does vitamin D deficiency account for ethnic differences in tuberculosis seasonality in the UK? Ethn Health. 1998 Nov;3(4):247–53.
1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 1998 Nov;66(11):5314–21.
Nutritional modulation of host responses to mycobacteria. Front Biosci. 1998 Jul 20;3:e110–22. Review.
Vitamin D administration to tuberculous children and its value. Boll Chim Farm. 1998 May;137(5):157–64.
The immunogenetics of human infectious diseases. Annu Rev Immunol. 1998;16:593–617. Review.
Host genetic susceptibility to human tuberculosis. Novartis Found Symp. 1998;217:3–13; discussion 13–23. Review.
Vitamin D theory gets another airing. Int J Tuberc Lung Dis. 1997 Dec;1(6):584.
Differences in vitamin D status and calcium intake: possible explanations for the regional variations in the prevalence of hypercalcemia in tuberculosis. Calcif Tissue Int. 1997 Jan;60(1):91–3.
Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong. Int J Clin Pharmacol Ther. 1996 Dec;34(12):533–4.
Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax. 1996 Sep;51(9):944–6.
Remission of hypercalciuria in patients with tuberculosis after treatment. Calcif Tissue Int. 1996 Jul;59(1):17–20.
Findings on host resistance genes for infectious diseases are pointing the way to drugs, vaccines. JAMA. 1996 May 15;275(19):1464–5.
Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine. Clin Infect Dis. 1995 Apr;20(4):982–91.
Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax. 1995 Feb;50(2):175–80.
The "vitamin D" endocrine and paracrine mediator in pulmonary granulomatosis. Rev Mal Respir. 1995;12(2):119–26. Review.
Primary hyperparathyroidism masked by antituberculous therapy-induced vitamin D deficiency. Clin Endocrinol (Oxf). 1994 Dec;41(6):831–6: discussion 837–8.
The prevalence of hypercalcaemia in pulmonary and miliary tuberculosis—a longitudinal study. Singapore Med J. 1994 Dec;35(6):613–5. Review.
Vitamin D metabolism by alveolar immune cells in tuberculosis: correlation with calcium metabolism and clinical manifestations. Eur Respir J. 1994 Jun;7(6):1103–10.
A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg. 1994 Feb;97(1):26–30.
The relationship between tuberculosis, vitamin D, potassium and AIDS. A message for South Africa? S Afr Med J. 1994 Feb;84(2):79–82.
Abnormal calcium and vitamin D metabolism in tuberculosis. Trop Geogr Med. 1994;46(5):280–2. Review.
Case report: hypercalcemia in a patient with AIDS and Pneumocystis carinii pneumonia. Am J Med Sci. 1993 Nov;306(5):313–6.
Dietary vitamin D affects cell-mediated hypersensitivity but not resistance to experimental pulmonary tuberculosis in guinea pigs. Infect Immun. 1993 May;61(5):2116–21.
Hypervitaminosis D. Nippon Rinsho. 1993 Apr;51(4):984–8. Review.
New faces, forgotten diseases:border medical examination of asylum seekers' children 1990–1991. Schweiz Med Wochenschr. 1992 Nov 28;122(48):1838–42.
Benefits of corticosteroids in the treatment of Horton's disease and rhizomelic pseudopolyarthritis: advantages and inconveniences. A meta-analysis. Rev Med Interne. 1992 Sep–Oct;13(5):387–91.
Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol. 1992 Mar;11(1):28–36. Review.
Tumour necrosis factor production by alveolar macrophages in pulmonary sarcoidosis and tuberculosis. Sarcoidosis. 1992 Mar;9(1):29–34.
Alterations in calcium metabolism in patients with active tuberculosis. Med Clin (Barc). 1991 Sep 7;97(7):245–9.
Hypercalcemia in active pulmonary tuberculosis. Ann Saudi Med. 1991 May;11(3):289–92.
Effect of vitamin D on efficacy of pyrazinamide in pulmonary tuberculosis. J Assoc Physicians India. 1991 May;39(5):425–6.
Hypercalcemia in a patient with tuberculous mediastinal lymphadenopathy. Singapore Med J. 1991 Feb;32(1):87–9.
Phosphocalcium metabolism disorders in patients with active pulmonary tuberculosis. Med Clin (Barc). 1991 Jan 26;96(3):92–4.
The blood serum systems in patients with tuberculosis. Probl Tuberk. 1991;(3):54–6.
Comparative abilities of various metabolites of vitamin D to protect cultured human macrophages against tubercle bacilli. J Leukoc Biol. 1990 Jun;47(6):545–50.
Calcium metabolism in tuberculosis. Kekkaku. 1990 Jun;65(6):415–20.
Calcium homeostasis in untreated pulmonary tuberculosis. I—Basic study. Genetika. 1990 Apr;26(4):749–59.
Subtypes of serum group specific component (Gc) in normal conditions and in pathology. Genetika. 1990 Apr;26(4):749–59.
Micronutrient status and immune function in tuberculosis. Ann N Y Acad Sci. 1990;587:59–69.
Hypercalcemia in pulmonary tuberculosis. Ups J Med Sci. 1990;95(2):157–60.
Abnormal synthesis of 1,25-dihydroxyvitamin D and hypercalcemia in children with tuberculosis. Pediatr Med Chir. 1989 Sep–Oct;11(5):529–32.
The role of vitamin D in tuberculosis. Am Rev Respir Dis. 1989 Jun;139(6):1571.
Hypercalcaemia in a child with miliary tuberculosis. Eur J Pediatr. 1989 Jun;148(7):650–1.
An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever. Immunology. 1989 May;67(1):126–8.
Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun. 1989 Mar;57(3):840–4.
1,25(OH)2-vitamin D3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages. Am Rev Respir Dis. 1989 Feb;139(2):549–52.
Are tuberculous patients at a great risk from hypercalcemia? Q J Med. 1988 Nov;69(259):869–78.
Vitamin D metabolism in tuberculosis. Production of 1,25(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am Rev Respir Dis. 1988 Oct;138(4):984–9.
The role of vitamin D in tuberculosis. Am Rev Respir Dis. 1988 Oct;138(4):768–70.
Sequential development of vitamin D metabolites under isoniazid and rifampicin therapy. Arch Fr Pediatr. 1988 Feb;45(2):145–8.
Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun. 1987 Dec;55(12):2945–50.
The effect of anti-tuberculosis chemotherapy on vitamin D and calcium metabolism. Tubercle. 1987 Dec;68(4):261–6.
Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis. 1987 Nov;71(5):341–4.
Miliary tuberculosis with hypercalcaemia and raised vitamin D concentrations. Thorax. 1987 Jul;42(7):555–6.
Hypercalcemia in active pulmonary tuberculosis. South Med J. 1987 May;80(5):572–6.
A case of active pulmonary tuberculosis with hypercalcemia. Nippon Naika Gakkai Zasshi. 1987 Mar;76(3):455–6.
Protein abnormalities in adult respiratory distress syndrome, tuberculosis, and cystic fibrosis sera. Proc Soc Exp Biol Med. 1987 Jan;184(1):74–82.
Vitamin D and tuberculosis. Tubercle. 1986 Jun;67(2):155–6.
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology. 1986 Jan;57(1):159–63.
Types of group-specific proteins, ceruloplasmin and transferrin in pulmonary tuberculosis patients. Probl Tuberk. 1986;(9):50–3.
Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis. Calcif Tissue Int. 1985 Dec;37(6):588–91.
A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle. 1985 Dec;66(4):301–6.
Hypercalcemia in granulomatous diseases: a dysfunction of vitamin D metabolism. Presse Med. 1985 Sep 28;14(32):1689–90.
A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle. 1985 Sep;66(3):187–91.
Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax. 1985 Aug;40(8):639–40.
Vitamin D 3 metabolism during anti-tuberculosis chemotherapy. Tubercle. 1985 Jun;66(2):151–2.
Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax. 1985 Mar;40(3):187–90.
Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism. Tubercle. 1985 Mar;66(1):49–54.
Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif Tissue Int. 1984 Sep;36(5):541–4.
Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India. 1984 Feb;32(2):185–8.
Ethnicity and health: a research review. Soc Sci Med. 1984;19(7):663–70. Review.
Serum calcium during chemotherapy for active pulmonary tuberculosis. Eur J Respir Dis. 1983 Jul;64(5):347–54.
Association between phosphoglucomutase (PGM1) and group-specific component (Gc) subtypes and tuberculosis. J Med Genet. 1983 Jun;20(3):220–2.
Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther. 1982 Oct;32(4):525–30.
Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis. J R Soc Med. 1982 Jul;75(7):533–6.
Serum calcium in pulmonary tuberculosis. Postgrad Med J. 1981 Nov;57(673):694–6.
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther. 1981 Sep;30(3):363–7.
The influence of vitamin D intake on serum calcium in tuberculosis. Acta Endocrinol (Copenh). 1981 May;97(1):114–7.
Content of vitamins C, D and B complex in the body of patients with pulmonary tuberculosis living in the northern national districts. Probl Tuberk. 1979 May;(5):43–7.
Hypercalcemia in active pulmonary tuberculosis. Ann Intern Med. 1979 Mar;90(3):324–8.
The current state of cutaneous tuberculosis. Z Gesamte Inn Med. 1978 Oct 1;33(19):726–31.
Hypercalcaemia and hypokalaemia in tuberculosis. Thorax. 1978 Aug;33(4):464–7.
The influence of nutrition response to infectious disease. Adv Vet Sci Comp Med. 1973;17:265–89. Review.
Evaluation of vitamin D deficiency in pulmonary tuberculosis. Probl Tuberk. 1973;51(8):46–9.
Influence of vitamin D 2 on the therapeutic effect of streptomycin in experimental tuberculosis. Antibiotiki. 1972 Jul;17(7):654–8.
Follow-up studies on kidney function in patients with cutaneous tuberculosis previously treated with massive doses of vitamin D. Arztl Forsch. 1969 Jun 10;23(6):207–11.
Treatment of cutaneous tuberculosis. Cah Coll Med Hop Paris. 1967 May 10;8(5):391–8.
The degree of calcination of organs and tissues under the effect of massive doses of vitamin D 2. Vrach Delo. 1966 Mar;3:44–7.
Minimal tuberculosis enteroperitonitis. Rev Esp Enferm Apar Dig Nutr. 1964 Jan;23:36–53.
On vitamin d therapy of non-hypovitaminosis diseases. Ther Ggw. 1963 Sep;102:980–94. Review.
Combined treatment of lupus tuberculosus patients with phtivazid, streptomycin and vitamin D-2. Sov Med. 1963 Jan;26:123–6.
Histological changes in tuberculous lupus of the skin treated with vitamin D2. Pr Kom Med Dosw. 1961;22(2):1–40.
Study of the evolution of therapy of cutaneous tuberculosis based on 423 cases treated from 1941 to 1958. Bull Acad Natl Med. 1959 Jan 3–Feb 27;143(3–4):93–6.
Protein fractions of blood serum in the course of skin tuberculosis treatment. Przegl Dermatol. 1958 Jul–Aug;8(4):419–27.
Mechanism of action of calcinosis factors. Arztl Forsch. 1958 May 10;12(5):I/264–6.
Treatment of cutaneous tuberculosis in children with phthivasid with vitamin D2. Sov Med. 1958 Apr;22(4):111–4.
Vitamin D2 poisoning by the usual therapeutic doses in a case of tuberculosis treated with PAS. Schweiz Med Wochenschr. 1958 Jan 4;88(1):9–13.
Finsen therapy and vitamin D. Acta Derm Venereol. 1958;38(4):264–73.
Effective method of therapy of tuberculous peritonitis. Probl Tuberk. 1958;36(5):58–63.
The present status of vitamin D2 in the treatment of lupus vulgaris. Dermatologica. 1957 Oct;115(4):491–5.
Vitamin D2 in tuberculosis. J Indian Med Assoc. 1957 Aug 1;29(3):90–3.
Modern therapy of cutaneous tuberculosis. Minerva Med. 1957 Jun 27;48(51):2269–73.
Treatment of lupus with vitamin D2 and phthivazine in association with reflex-segmentary application of paraffin and mustard. Vestn Dermatol Venerol. 1957 May–Jun;31(3):41–3.
Hormonal effects of chemotherapy of cutaneous tuberculosis. Arch Klin Exp Dermatol. 1957;206:676–82.
Role of the calcinosis factor (vitamin D, dihydrotachysterin) in therapy of tuberculosis. Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1957;117(2):265–75.
Curing of cold abscess with large doses of vitamin D 2. Gazz Med Ital. 1956 Dec;115(12):441–2.
Use of calcium and vitamin D in tuberculosis of the bones. Klin Med (Mosk). 1956 Dec;34(12):82–4.
Studies on pH in lupus vulgaris treated with calciferol. Przegl Dermatol. 1956 Sep–Oct;6(5):419–34.
Microflocculation test for tuberculosis; a preliminary note. Am J Clin Pathol. 1956 Mar;26(3):327–8.
Chemotherapy and vitamin D therapy of skin tuberculosis. Ergeb Gesamten Tuberkuloseforsch. 1956;13:331–70.
Lupus vulgaris; its anatomopathological development during general treatment. Ann Dermatol Syphiligr (Paris). 1955 Sep–Oct;82(5):520–31.
Treatment of lupus vulgaris with calciferol alone; results after five years of observation. Dan Med Bull. 1955 Sep;2(5):129–36.
Venous reactions in tuberculous lupus during therapy with vitamin D2. Vestn Venerol Dermatol. 1955 Sep–Oct;(No 5):18–22.
Lupus vulgaris of mucosa and nasal cutis. Arch Ital Otol Rinol Laringol. 1955 May–Jun;66(3):407–15.
Tuberculous mesenteric adenitis in children. Br Med J. 1955 Jan 15;1(4906):128–33.
Effects of vitamin D2 and isoniazid therapy on the state of lupus control. Dermatol Wochenschr. 1955;132(37):961–6.
Six years of calciferol therapy in tuberculosis of the skin. Dermatologica. 1954 Dec;109(6):355–69.
Therapy of lupus tuberculosus with radioactive phosphorus associated with vitamin D2. Vestn Rentgenol Radiol. 1954 Sep–Oct;5:14–7.
Treatment of lupus vulgaris with newer drugs. N Y State J Med. 1954 Jul 15;54(14):2095–6.
Therapy of cutaneous tuberculosis. J Med (Oporto). 1953 Dec 5;22(567):1193–1204.
Value of streptomycin, calciferol and sulphones in cutaneous tuberculosis. J Indian Med Assoc. 1953 Aug;22(11):436–44.
Local treatment of tuberculous tension cavities. J Egypt Med Assoc. 1953;36(7):59–73.
The question of late injuries in long lasting vitamin D treatment of cutaneous tuberculosis. Z Tuberk. 1953;103(1–3):26–50.
Papular necrotic tuberculid developing during calciferol therapy. AMA Arch Derm Syphilol. 1952 May;65(5):610–3.
Treatment of ocular tuberculosis with vitamin D2; preliminary report. Vojnosanit Pregl. 1952 Mar–Apr;9(3–4):114–6.
The tuberculostatic action of vitamin D2. Antonie Van Leeuwenhoek. 1952;18(3):217–26.
Treatment of lupus vulgaris by intralesional injections of calciferol; its use in localized, recurrent, or refractory cases. AMA Arch Derm Syphilol. 1951 Dec;64(6):676–83.
Calciferol, streptomycin, and para-aminosalicylic acid in pulmonary tuberculosis. Lancet. 1951 Oct 6;2(6684):614–7.
Calciferol in the treatment of lupus vulgaris. Ugeskr Laeger. 1950 Nov 2;112(44):1525.
Cutaneous tuberculosis and its treatment with calciferol. Med Womans J. 1950 Aug;57(8):7–20.
Vitamin D2 in cutaneous tuberculosis; (progress report). Acta Med Philipp. 1950 Jul–Sep;7(1):55–9.
Treatment of lupus erythematosus with calciferol, antibiotics and gold preparations. Arch Derm Syphilol. 1950 Jun;61(6):909–12.
The treatment of skin tuberculosis with calciferol. Dermatologica. 1950;101(1):1–16.
Treatment of lupus vulgaris with calciferol (vitamin D2). Arch Derm Syphilol. 1949 Oct;60(4):614–23.
The modern role of vitamin D2 in cutaneous tuberculosis with a preliminary report on five cases. Acta Med Philipp. 1949 Jan–Mar;5(3):17–23.
The effect of nonirradiated ergosterol in calciferol-treated tuberculosis cutis. Dermatologica. 1949;99(6):345–52.
Calciferol-resistant cases of lupus. Dermatologica. 1949;98(2):76–9.
Lupus vulgaris and vitamin D. Can Med Assoc J. 1948 Dec;59(6):522–7.
Leprosy in British nationals. Br J Dermatol Syph. 1948 Apr;60(4):139–43.
Vitamin D therapy in cutaneous tuberculosis. Br J Dermatol Syph. 1948 Apr;60(4):132–9.
Vitamin D in the treatment of cutaneous tuberculosis. Br J Dermatol Syph. 1948 Apr;60(4):127–31.
Vitamin D in treatment of cutaneous tuberculosis. Br Med J. 1948 Mar 6;1(4548):430–5.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.